Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
10-Fold Quantum Yield Improvement of Ag2S Nanoparticles by Fine Compositional Tuning.
Ortega-Rodríguez A, Shen Y, Zabala Gutierrez I, Santos HDA, Torres Vera V, Ximendes E, Villaverde G, Lifante J, Gerke C, Fernández N, Calderón OG, Melle S, Marques-Hueso J, Mendez-Gonzalez D, Laurenti M, Jones CMS, López-Romero JM, Contreras-Cáceres R, Jaque D, Rubio-Retama J. Ortega-Rodríguez A, et al. Among authors: gerke c. ACS Appl Mater Interfaces. 2020 Mar 18;12(11):12500-12509. doi: 10.1021/acsami.9b22827. Epub 2020 Mar 9. ACS Appl Mater Interfaces. 2020. PMID: 32069007
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.
Brunet J, Choucha Z, Gransagne M, Tabbal H, Ku M-W, Buchrieser J, Fernandes P, Batalie D, Lopez J, Ma L, Dufour E, Simon E, Hardy D, Petres S, Guinet F, Strick-Marchand H, Monot M, Charneau P, Majlessi L, Duprex WP, Gerke C, Martin A, Escriou N. Brunet J, et al. Among authors: gerke c. J Virol. 2024 May 14;98(5):e0169323. doi: 10.1128/jvi.01693-23. Epub 2024 Apr 2. J Virol. 2024. PMID: 38563763 Free article.
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.
Nambulli S, Escriou N, Rennick LJ, Demers MJ, Tilston-Lunel NL, McElroy AK, Barbeau DJ, Crossland NA, Hoehl RM, Schrauf S, White AG, Borish HJ, Tomko JA, Frye LJ, Scanga CA, Flynn JL, Martin A, Gerke C, Hartman AL, Duprex WP. Nambulli S, et al. Among authors: gerke c. J Virol. 2024 May 14;98(5):e0176223. doi: 10.1128/jvi.01762-23. Epub 2024 Apr 2. J Virol. 2024. PMID: 38563762 Free article.
Diverse cytomegalovirus US11 antagonism and MHC-A evasion strategies reveal a tit-for-tat coevolutionary arms race in hominids.
Zimmermann C, Watson GM, Bauersfeld L, Berry R, Ciblis B, Lan H, Gerke C, Oberhardt V, Fuchs J, Hofmann M, Freund C, Rossjohn J, Momburg F, Hengel H, Halenius A. Zimmermann C, et al. Among authors: gerke c. Proc Natl Acad Sci U S A. 2024 Feb 27;121(9):e2315985121. doi: 10.1073/pnas.2315985121. Epub 2024 Feb 20. Proc Natl Acad Sci U S A. 2024. PMID: 38377192
65 results